DNA X, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- DNA X, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $53.00K.
- DNA X, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-12-31 was $0.00.
- DNA X, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $419.00K.
- DNA X, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- DNA X, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $419.00K.
- DNA X, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $5.00K, a 98.69% decline from fiscal 2020.
- DNA X, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $382.00K, a 371.60% increase from fiscal 2019.
- DNA X, Inc. stock issued during period, value, stock options exercised for fiscal 2019 was $81.00K, a 376.47% increase from fiscal 2018.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-03-31 | $53.00K 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $419.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $419.00K 10-Q · filed 2024-11-13 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $5.00K 10-K · filed 2023-03-20 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $83.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $84.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $5.00K 10-Q · filed 2022-05-10 | $177.00K derived: sum of 4 quarters · filed 2022-06-29 |
| 2020-12-31 | $78.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-06-29 | $382.00K 10-K/A · filed 2022-06-29 |
| 2020-09-30 | $1.00K 10-Q/A · filed 2022-06-29 | $316.00K derived: sum of 4 quarters · filed 2022-06-29 |
| 2020-06-30 | $93.00K 10-Q/A · filed 2022-06-29 | $329.00K derived: sum of 4 quarters · filed 2022-06-29 |
| 2020-03-31 | $210.00K 10-Q · filed 2021-05-11 | $250.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $81.00K 10-K · filed 2021-03-18 |
| 2019-09-30 | $14.00K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $14.00K 10-Q · filed 2020-08-12 | |
| 2019-03-31 | $41.00K 10-Q · filed 2020-05-14 | |
| 2018-12-31 | $17.00K 10-K · filed 2020-03-27 | |
| 2018-03-31 | $11.00K 10-Q · filed 2019-06-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CLEARONE INC (CLRO) | United States | $0.009B | |
| FRANKLIN WIRELESS CORP (FKWL) | United States | $0.028B | -61.80 |
| FiEE, Inc. (FIEE) | Japan | $0.033B | 8.06 |
| Clearfield, Inc. (CLFD) | United States | $0.415B | -74.88 |
| ADTRAN Holdings, Inc. (ADTN) | United States | $0.565B | -43.25 |
| Fabrinet (FN) | $14.287B | 39.79 | |
| CIENA CORP (CIEN) | United States | $50.874B | 81.72 |